openPR Logo
Press release

Macular Degeneration Treatment Global Market Forecast 2023-2032 : By Industry Analysis, Size, Share, Major Players Are - Novartis AG, Regenxbio Inc., GlaxoSmithKline plc, Bayer AG, StemCells Inc.

03-23-2023 08:31 AM CET | Health & Medicine

Press release from: The Business research company

Macular Degeneration Treatment Market Analysis

Macular Degeneration Treatment Market Analysis

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per the macular degeneration treatment market report by The Business Research Company, The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market. Retinal disorders affect the vital tissue and affect the way individuals process visual information, leading to distorted or absent vision.

The global macular degeneration treatment market size grew from $8.44 billion in 2022 to $9.43 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The macular degeneration treatment market size is expected to grow to $14.3 billion in 2027 at a CAGR of 11.0%.

Read More On The Macular Degeneration Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

Major competitors in the Macular Degeneration Treatment market include Novartis AG, Bausch Health Companies Inc., Regenxbio Inc., F Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc., Ophthotech Corporation, StemCells Inc., Pfizer Inc., Santen Pharmaceuticals, Alimera Sciences Inc., Aerie Pharmaceutical Inc., Panoptica, Allergan Inc., Valeant Pharmaceuticals, and Rxi Pharmaceuticals Inc.

The Macular Degeneration Treatment market is segmented -
By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

By Route of Administration: Oral, Injectable, Other Route of Administration

By Types: Wet Macular Degeneration, Dry Macular Degeneration

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Macular Degeneration Treatment market.

Request A Free Sample Of The Macular Degeneration Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp

Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). The macular degeneration treatment is used to treat macular degeneration eye disease and slow the disease and prevent severe loss of vision.

The Table Of Content For The Macular Degeneration Treatment Market Include:
1. Executive Summary
2. Macular Degeneration Treatment Market Characteristics
3. Macular Degeneration Treatment Market Trends And Strategies
4. Macular Degeneration Treatment Market - Macro Economic Scenario
5. Macular Degeneration Treatment Market Size And Growth
……
26. Africa Macular Degeneration Treatment Market
27. Macular Degeneration Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market
29. Macular Degeneration Treatment Market Future Outlook and Potential Analysis
30. Appendix

The "Global Macular Degeneration Treatment Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macular Degeneration Treatment Global Market Forecast 2023-2032 : By Industry Analysis, Size, Share, Major Players Are - Novartis AG, Regenxbio Inc., GlaxoSmithKline plc, Bayer AG, StemCells Inc. here

News-ID: 2986051 • Views:

More Releases from The Business research company

Emerging Growth Patterns, Segment Analysis, and Competitive Approaches Influencing the Multi-Fiber Push On (MPO) or Mechanical Transfer Push-On (MTP) Cabling Assemblies Market
Emerging Growth Patterns, Segment Analysis, and Competitive Approaches Influenci …
The multi-fiber push on (MPO) or mechanical transfer push-on (MTP) cabling assemblies market is on track for significant expansion in the coming years, driven by advancements in data transmission technology and increasing demand for efficient connectivity solutions. As digital transformation accelerates across industries, these cabling assemblies are becoming essential components in modern network infrastructure. Below is a detailed overview of the market's size, key drivers, leading players, trends, and main
Analysis of Key Market Segments Driving the Microproteins Skincare Market
Analysis of Key Market Segments Driving the Microproteins Skincare Market
The microproteins skincare market is gaining significant traction as consumers increasingly seek effective, science-driven beauty solutions. With innovations in peptide technology and a growing focus on personalized skincare, this market is on a promising growth trajectory. Let's explore the current market size, leading players, influential trends, and segmentation details shaping this dynamic sector. Projected Growth and Market Size of the Microproteins Skincare Market The microproteins skincare market is projected to experience robust
Market Trend Analysis: The Impact of Recent Innovations on the Medical Device Brazing Service Market
Market Trend Analysis: The Impact of Recent Innovations on the Medical Device Br …
The medical device brazing service market is on track for substantial growth in the coming years, driven by advancing technologies and evolving healthcare needs. As the demand for reliable and efficient medical devices rises, the brazing services that enable precision joining of components are becoming increasingly vital. Let's explore the market size projections, key players, segmentation details, and emerging trends shaping this industry. Medical Device Brazing Service Market Size and Growth
Segmentation, Major Trends, and Competitive Overview of the Lifestyle-Related Disease Supplements Market
Segmentation, Major Trends, and Competitive Overview of the Lifestyle-Related Di …
The lifestyle-related disease supplements market is rapidly evolving as consumers become more health-conscious and proactive about managing chronic conditions linked to lifestyle choices. With an aging global population and increasing disposable incomes, this sector is set for impressive growth. Let's explore the market size, key players, trends, and segmentation that are shaping its future trajectory. Projected Market Size and Growth Rate for Lifestyle-Related Disease Supplements The lifestyle-related disease supplements market is on

All 5 Releases


More Releases for Degeneration

Emerging Cartilage Degeneration Market Trends: Innovative Products Transforming …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Cartilage Degeneration Market Size Growth Forecast: What to Expect by 2025? In recent times, the market size for cartilage degeneration has witnessed robust growth. It is projected to rise from $12.63 billion in 2024 to $13.4 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. Factors
Growing Retinal Disorder Incidence Propels Macular Degeneration Treatment Market …
The Macular Degeneration Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Macular Degeneration Treatment Market Size and Its Estimated Growth Rate? Recent years have witnessed significant growth in the macular degeneration treatment market. The market size is projected to increase from
Top Factor Driving Macular Degeneration Treatment Market Growth in 2025: Growing …
Which drivers are expected to have the greatest impact on the over the macular degeneration treatment market's growth? The growth of the macular degeneration treatment market is poised to be catalyzed by the escalating issue of retinal disorders. These disorders compromise a crucial tissue and consequently disrupt the way our eyes process visual input, often resulting in blank or warped vision. For instance, data gathered by the American Academy of Ophthalmology
Global Age-Related Macular Degeneration Market Forecast Report by Disease Type ( …
Age-Related Macular Degeneration Market Analysis The global age-related macular degeneration (AMD) market is projected to reach USD 19.53 billion by 2032, up from USD 10.68 billion in 2023, with a compound annual growth rate (CAGR) of 6.94% from 2024 to 2032. The market's expansion is driven by an aging population susceptible to macular cell damage due to changes in retinal structure and blood flow. Additional factors contributing to this growth include
Exploring Cartilage Degeneration Market Trends 2024
The cartilage degeneration market size has grown strongly in recent years. It will grow from $11.88 billion in 2023 to $12.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to aging population, joint injuries, obesity epidemic, sports injuries, limited self-repair capacity. The cartilage degeneration market size is expected to see strong growth in the next few
Wet Age-Related Macular Degeneration Pipeline 2024
DelveInsight's, "Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024," report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet-AMD) pipeline landscape. It covers the Wet Age-Related Macular Degeneration pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key